Lonial, S., Nooka, A. K., Thulasi, P., Badros, A. Z., Jeng, B. H., Callander, N. S., . . . Jakubowiak, A. (2021). Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM). Blood Cancer J.
Παραπομπή Chicago StyleLonial, Sagar, et al. "Management of Belantamab Mafodotin-associated Corneal Events in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)." Blood Cancer J 2021.
Παραπομπή MLALonial, Sagar, et al. "Management of Belantamab Mafodotin-associated Corneal Events in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)." Blood Cancer J 2021.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.